Cancer of the Testis

ISBN-13: 9781848003699 / Angielski / Twarda / 2010 / 347 str.

M. P. Laguna; M. Pilar Laguna; Peter Albers

Opis

The book covers the complete field of testis cancer including the germ cell tumors and the stromal tumors, from epidemiology to new chemotherapeutic agents and schedules, throughout genetic features, risk factors, risk adapted treatments, role of different types of surgery and special clinical situations. Special attention is focused on fertility issues, late effects of the primary therapy and the economical aspects of the different treatment policies. As a result of the third Consensus Conference, a consensual follow-up can be devised and a chapter dedicated to this controversial and not yet defined matter. This book is the state-of-the-art reference text on testis cancer and is an essential resource for all urologists, medical oncologists and radio-oncologists.

Recenzje

From the reviews:

"This is an excellent resource not only for diagnosis and staging, but also as an overview of contemporary management. ... The book is intended for clinicians who wish to review and broaden their knowledge in this area. ... Each chapter in this book is well written and provides excellent discourse on its topic. This is a very good resource for clinicians who seek an overview of the relevant multifaceted aspects of testis cancer." (Timothy J. Kim, Doody's Review Service, August, 2011)

"M. Pilar Laguna, P. Albers, C. Bokeleyer and J. P. Richie developed a transatlantic cooperation and wrote this outstanding book with the help of more than 50 recognised experts. All medical specialities involved in testis cancer management were represented ... . All aspects of testis cancer were examined with the main contents divided into six parts. ... This textbook was intended for urologists and all physicians involved in testis cancer management, a many will find practical information in this publication." (Paul Meria, European Urology Today, April/May, 2011)

Spis treści

Histological Classification and Pathology of Testicular Tumors.- Risk Factors and Genetical Characterization.- Primary Non-Germ Cell Tumors of the Testis.- Staging and Prognostic Systems.- Testicular Tumor Markers.- Radical Orchiectomy and Testis Sparing Procedures for the Management of Germ Cell Tumors.- CIS and Bilateral Cancer: Clinical Presentations and Diagnostics.- Diagnostic and Therapeutic Laparoscopic Retroperitoneal Lymph Node Dissection: The American View.- Laparoscopic Retroperitoneal Lymph Node Dissection for Stage I and II: The European View.- Radiographic Diagnosis and Staging.- Treatment of Non-Seminoma: Stage I.- Treatment of Patients with Stage II A/B and Advanced Nonseminomatous Germ Cell Tumors.- Treatment of Seminoma: Stage I.- Stage II Seminoma and Advanced Disease.- Treatment of Relapse.- Post-Chemotherapy Retroperitoneal Lymph Node Dissection.- Surgical Resection at Other Sites.- Extra Gonadal Germ Cell Tumors.- New Systemic Therapies for Refractory Tumors.- Management of Late Relapse.- Testicular Cancer: Late Effects of Treatment.- Fertility Issues.- Follow-Up after Primary Treatment.- Testicular Cancer in Childhood.

Blurb

Cancer of the Testis presents a thorough account of every aspect of this disease, including histology, risk factors, prognosis, clinical presentation, diagnosis and treatment. Additionally, there is a focus on the pertinent issues of fertility, late effects of primary therapy, follow-up after primary treatment and testicular cancer in childhood.

With an international authorship comprised of many of the key contributors to the field, this book brings together a rich and balanced range of perspectives.

A state-of-the-art reference volume on testicular cancer, this book is essential reading for urologists, medical oncologists and radio-oncologists.

M. Pilar Laguna, MD PhD, is an Associate Professor in Urology at the University of Amsterdam, The Netherlands.

Peter Albers, MD, is Chairman of the Department of Urology at Dusseldorf University, Germany.

Carsten Bokemeyer, MD, is Director of Oncology and Hematology at Hubertus Wald Tumorzentrum at the University Medical Center in Hamburg, Germany.

Jerome P. Richie, MD, is the Elliot C. Cutler Professor of Urologic Surgery at Harvard Medical School and Chief of Urology at Brigham and Women’s Hospital in Boston, USA.